Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 15, 2026

Knee Arthrocentesis in Adults
04:41

Knee Arthrocentesis in Adults

Published on: February 25, 2022

EVALUATION OF THE RADIOISOTOPIC SYNOVECTOMY PROTOCOL IN PATIENTS WITH HEMOPHILIA.

Marcela Dos Santos Martins1, Janaina Bosso da Silva Ricciardi1, Allan de Oliveira Santos1

  • 1Universidade Estadual de Campinas (UNICAMP), Faculdade de Ciencias Medicas, Sao Paulo, SP, Brazil.

Acta Ortopedica Brasileira
|May 14, 2026
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New Treatment in Haemophilia: Challenges, Controversies and Uncertainties.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same author

Exercise Programmes for People With Haemophilia: A Scoping Review.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same author

Plain Language Summary on Safety and Efficacy of Damoctocog Alfa Pegol in Previously Treated Children Aged 7 to < 12 Years With Severe Haemophilia A in the Phase 3, Open Label Alfa-PROTECT Main Study.

European journal of haematology·2026
Same author

Safety and Efficacy of Damoctocog Alfa Pegol in Previously Treated Children Aged 7 to < 12 Years With Severe Haemophilia A in the Phase 3, Open Label Alfa-PROTECT Main Study.

European journal of haematology·2026
Same author

ASSESSMENT OF ISOMETRIC AND ISOKINETIC ANKLE STRENGTH MEASURES: A PILOT STUDY.

Acta ortopedica brasileira·2025
Same author

IMPLEMENTATION OF WALANT ANESTHESIA FOR HAND AND WRIST SURGERIES IN A TERTIARY HOSPITAL: PILOT STUDY.

Acta ortopedica brasileira·2025

Radioisotopic synovectomy (RS) significantly reduced bleeding events in hemophilia patients by 44.68%. This safe and effective procedure offers a valuable treatment option for managing hemophilic arthropathy and preventing joint destruction.

Area of Science:

  • Orthopedics
  • Hematology
  • Nuclear Medicine

Background:

  • Hemophilia commonly causes intra-articular hemorrhage, leading to chronic synovitis and joint destruction.
  • Conservative treatments may fail to halt synovitis progression in hemophilic arthropathy.
  • Radioisotopic synovectomy (RS) is a treatment option to interrupt joint destruction by removing inflamed synovium.

Purpose of the Study:

  • To evaluate the safety and effectiveness of radioisotopic synovectomy (RS) in reducing hemarthrosis incidence.
  • To assess the impact of RS on bleeding events in hemophilia patients.

Main Methods:

  • Retrospective study analyzing medical records of patients undergoing RS.
  • Comparison of bleeding event frequency one year before and one year after RS.
Keywords:
HemophiliaJoint diseasesRadioisotopesSynovectomy

Related Experiment Videos

Last Updated: May 15, 2026

Knee Arthrocentesis in Adults
04:41

Knee Arthrocentesis in Adults

Published on: February 25, 2022

  • Statistical analysis using the Wilcoxon signed-rank test.
  • Main Results:

    • 65 RS procedures were performed between 2008 and 2018.
    • A significant reduction in bleeding events from 367 to 203 (44.68% decrease, P<0.001) was observed post-RS.
    • No procedure-related complications were reported.

    Conclusions:

    • Radioisotopic synovectomy (RS) is a safe and effective treatment for reducing bleeding events in hemophilia patients.
    • RS can help manage chronic synovitis and prevent further joint damage in hemophilic arthropathy.
    • The study supports RS as a valuable therapeutic option for hemophilia management.